Certified by Founder Lodge
BrightEdge - American Cancer Society
United States - Atlanta, Georgia
INVESTOR
1 Disclosed Funding Rounds $41,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BrightEdge is the American Cancer Society’s impact investment arm that, through equity investment seeks to translate groundbreaking cancer research into commercially accessible solutions, dee
| Company | Date | Round | Raised |
|---|---|---|---|
 Mercy BioAnalytics, Inc. |
April, 04 ,2023 | Series A | $41,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
